2021
DOI: 10.1056/nejmoa2027278
|View full text |Cite|
|
Sign up to set email alerts
|

Tympanostomy Tubes or Medical Management for Recurrent Acute Otitis Media

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
21
0
5

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 39 publications
(26 citation statements)
references
References 21 publications
0
21
0
5
Order By: Relevance
“…Secretory otitis media is a common disease in clinical pediatrics among infants and toddlers, whereby delayed treatment causes hearing loss [ 1 ]. Secretory otitis media is mainly characterized by ear aches, tinnitus, ear discomfort, hearing loss, and middle ear effusion [ 2 ].…”
Section: Introductionmentioning
confidence: 99%
“…Secretory otitis media is a common disease in clinical pediatrics among infants and toddlers, whereby delayed treatment causes hearing loss [ 1 ]. Secretory otitis media is mainly characterized by ear aches, tinnitus, ear discomfort, hearing loss, and middle ear effusion [ 2 ].…”
Section: Introductionmentioning
confidence: 99%
“…A more recent US randomized controlled trial among 250 children 6 to 35 months of age with recurrent AOM found no significant difference in the rate of episodes of AOM during a 2-year period in the intention-to-treat analysis (mean of 1.5 episodes, risk ratio 0.97; 95% CI 0.84 to 1.12; P=.66). 16 The time to first occurrence of AOM was longer in the TT group than in the observation group (4.34 months vs 2.33 months; hazard ratio=0.68, 95% CI 0.52 to 0.90). Children in the TT group had higher mean (SD) days per year with tube otorrhea (7.96 [1.10] vs 2.83 [0.78] days) but had fewer mean (SD) days per year with other otitis-related symptoms (2.00 [0.29] vs 8.33 [0.59] days).…”
Section: Myringotomy With Tt Insertionmentioning
confidence: 85%
“…11 Since the introduction of PCV7 and PCV13 there have been 3 main studies comparing the efficacy of TT insertion versus observation with episodic antimicrobial therapy among children with recurrent AOM. [14][15][16] A retrospective matched cohort study among more than 13,000 children younger than 5 years of age with recurrent AOM reported that the TT group had a lower 1-year incidence of episodes of AOM (1.96 vs 2.18, respectively; P<.001) and fewer oral antibiotic prescriptions (1.52 vs 1.67; P<.001). 14 However, at the 2-year follow-up, the difference between the TT group and the medically managed group was no longer significant for episodes of AOM (1.69 vs 1.66; P=.384) or number of oral antibiotic prescriptions (0.91 vs 0.87; P=.09).…”
Section: Myringotomy With Tt Insertionmentioning
confidence: 99%
“… 7 Although TTs may not decrease the number of AOM episodes compared to medical management over the ensuing 2 years after placement, they do appear to reduce symptom severity and the need for oral antibiotics while increasing the time to a first occurrence of AOM. 8 Another study found that TT did not decrease the rate of new AOM episodes but did decrease the percentage of time with AOM compared to placebo. 7 Research on the occurrence of adverse events that may occur after TT placement surgery has also been challenging to synthesize because highly variable definitions are often used and follow‐up outcomes and duration are different between different studies, though there is literature exploring some of the most commonly reported adverse events after TT placement.…”
Section: Introductionmentioning
confidence: 99%
“…Otorrhea is a common occurrence after TT placement. 8 Van Dongen et al found that two‐thirds of children with TT experienced at least one episode of otorrhea in the year following placement. 9 They also determined that otorrhea in children with TT could be predicted by age, a recent history of upper respiratory tract infections, and the presence of older siblings.…”
Section: Introductionmentioning
confidence: 99%